Literature DB >> 17885771

[Transdermal and oral opioids for outpatient pain therapy. Comparing patients' characteristics by a claims data analysis].

A Höer1, M Kurepkat, A Gottberg, B Häussler.   

Abstract

Opioid prescriptions have increased in Germany in recent years. The usage of transdermal therapeutic systems has substantially driven this growth. The analysis was based on claims data of a German statutory health insurance (2001-2003). Statistical analysis applied univariate comparisons (exploratively only) as well as a multivariate logistic regression models. Patients in the transdermal group were older and the percentage of women was higher than in the oral group. Patients in the transdermal group received their opioids significantly more often from a GP. They had significantly less prescriptions for laxatives and antidepressants. The patients in both groups differed significantly with regard to a number of characteristics. The results indicate that GPs prefer transdermal opioids if prescribing strong-acting opioids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17885771     DOI: 10.1007/s00482-007-0575-y

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  5 in total

1.  [Strong opioids and constipation].

Authors:  A Schwarzer; F Nauck; E Klaschik
Journal:  Schmerz       Date:  2005-06       Impact factor: 1.107

Review 2.  Cancer pain relief and palliative care. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1990

3.  Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine.

Authors:  L Radbruch; R Sabatowski; G Loick; C Kulbe; M Kasper; S Grond; K A Lehmann
Journal:  Palliat Med       Date:  2000-03       Impact factor: 4.762

4.  Buprenorphine TDS: use in daily practice, benefits for patients.

Authors:  Lukas Radbruch
Journal:  Int J Clin Pract Suppl       Date:  2003-02

5.  Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain.

Authors:  L Allan; H Hays; N H Jensen; B L de Waroux; M Bolt; R Donald; E Kalso
Journal:  BMJ       Date:  2001-05-12
  5 in total
  2 in total

Review 1.  [Opioids in chronic noncancer pain-are opioids different? A systematic review and meta-analysis of efficacy, tolerability and safety in randomized head-to-head comparisons of opioids of at least four week's duration].

Authors:  R Lauche; P Klose; L Radbruch; P Welsch; W Häuser
Journal:  Schmerz       Date:  2015-02       Impact factor: 1.107

2.  [Prescription of high-potency opioids in 2011].

Authors:  F Hoffmann; G Glaeske; R Windt
Journal:  Schmerz       Date:  2012-12       Impact factor: 1.107

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.